Search contract descriptions, companies and agencies.
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Total Committed Value of Federal Contracts
$4.06M
Recent Contract Actions
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Description |
Category |
Agency |
Signed |
Amount Committed |
| COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
August 05, 2021 |
$0 |
| UGA CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
March 26, 2021 |
$1,000,000 |
| SARS-COV-2 APPLIED RESEARCH |
Biomedical R&D |
Centers for Disease Control and Prevention |
January 29, 2021 |
$1,116,539 |
| COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
October 15, 2020 |
$0 |
| COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
August 17, 2020 |
$1,939,401 |
| COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
May 13, 2020 |
$0 |
About this data
This data comes from the
Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the
procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a
90-day delay before it appears in the data.
